Last update 07 Feb 2026

HQL-79

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HQL-79
Target
H-PGDS
Action
inhibitors
Mechanism
H-PGDS inhibitors(hematopoietic prostaglandin D synthase inhibitors)
Therapeutic Areas
Nervous System DiseasesOther DiseasesImmune System Diseases
Active Indication-
Inactive Indication
Brain Injuries, TraumaticHypersensitivity
Originator Organization
Sumitomo Metal Industries Ltd.
Active Organization-
Inactive Organization
Sumitomo Metal Industries Ltd.
Osaka Bioscience InstituteOsaka Bioscience Institute
License Organization-
Drug Highest PhaseDiscontinuedPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with HQL-79
Login to view more data
100 Translational Medicine associated with HQL-79
Login to view more data
100 Patents (Medical) associated with HQL-79
Login to view more data
20
Literatures (Medical) associated with HQL-79
01 Nov 2024ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Discovering potential asthma therapeutics targeting hematopoietic prostaglandin D2 synthase: An integrated computational approach
01 Nov 2019FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Crth2 receptor signaling down‐regulates lipopolysaccharide‐induced NF‐αB activation in murine macrophages via changes in intracellular calcium
01 Dec 2018The Journal of pharmacology and experimental therapeuticsQ3 · MEDICINE
Lipocalin-Like Prostaglandin D Synthase but Not Hemopoietic Prostaglandin D Synthase Deletion Causes Hypertension and Accelerates Thrombogenesis in Mice
Q3 · MEDICINE
100 Deals associated with HQL-79
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Brain Injuries, TraumaticPreclinical
Japan
Osaka Bioscience InstituteOsaka Bioscience Institute
11 Nov 2003
HypersensitivityDiscovery
Japan
Sumitomo Metal Industries Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free